Cargando…
Convalescent plasma therapy for patients with severe COVID-19: A case series study
Coronavirus disease 2019 (COVID-19) is a novel acute respiratory infectious disease that can lead to multiple-organ dysfunction in patients with severe disease. However, there is a lack of effective antiviral drugs for COVID-19. Herein, we investigated the efficacy and safety of convalescent plasma...
Autores principales: | Huang, Jinbao, Weng, Heng, Lan, Changqing, Li, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351516/ https://www.ncbi.nlm.nih.gov/pubmed/35945787 http://dx.doi.org/10.1097/MD.0000000000029912 |
Ejemplares similares
-
Disseminated cryptococcal infection with pulmonary involvement presenting as diffuse cavitary nodules in an immunocompromised patient: a case report
por: Huang, Jinbao, et al.
Publicado: (2023) -
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
por: Duan, Kai, et al.
Publicado: (2020) -
Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency
por: Lang-Meli, Julia, et al.
Publicado: (2021) -
Efficacy of convalescent plasma therapy in severe COVID-19 patients
por: Akay Cizmecioglu, Hilal, et al.
Publicado: (2021) -
A severe refractory COVID-19 patient responding to convalescent plasma; A case series
por: Abdullah, Hadi Mohammed, et al.
Publicado: (2020)